CELSENTRI

This brand name is authorized in Australia, Austria, Brazil, Canada, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Netherlands, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug CELSENTRI contains one active pharmaceutical ingredient (API):

1	Maraviroc UNII MD6P741W8A - MARAVIROC
	Maraviroc is a member of a therapeutic class called CCR5 antagonists. Maraviroc selectively binds to the human chemokine receptor CCR5, preventing CCR5-tropic HIV-1 from entering cells.
	Read more about Maraviroc

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CELSENTRI Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J05AX09	Maraviroc	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AX Other antivirals
Discover more medicines within J05AX09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10318C, 10355B
BR	Câmara de Regulação do Mercado de Medicamentos	510612403113312, 510612406112317, 510612410111311, 510612414115311
CA	Health Products and Food Branch	02299844, 02299852
EE	Ravimiamet	1347274, 1347285, 1347296, 1347308, 1347319, 1347320, 1347331, 1347342, 1750508, 1750519, 1750520
ES	Centro de información online de medicamentos de la AEMPS	07418003, 07418008
FI	Lääkealan turvallisuus- ja kehittämiskeskus	061092, 166487
FR	Base de données publique des médicaments	60992262, 61182724, 62094362, 64933044, 65936214
GB	Medicines & Healthcare Products Regulatory Agency	126610, 126613, 348834, 348849, 348852
HK	Department of Health Drug Office	56786, 56798
IL	מִשְׂרַד הַבְּרִיאוּת	6279, 6280
JP	医薬品医療機器総合機構	6250034F1025
LT	Valstybinė vaistų kontrolės tarnyba	1028289, 1028290, 1028291, 1028292, 1028293, 1028294, 1028295, 1028296, 1028297, 1028298, 1083705, 1083706, 1083707
NL	Z-Index G-Standaard, PRK	149942, 149950, 85413, 85421
PL	Rejestru Produktów Leczniczych	100180170, 100180186, 100387125, 100387154, 100387160
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64977001, W64977002, W64977003, W64977004, W64977005, W64978001, W64978002, W64978003, W64978004, W64978005, W64979001, W64980001, W64981001
SG	Health Sciences Authority	13640P, 13641P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522094493, 8699522094509, 8699522094516, 8699522094523, 8699522094547, 8699522094554, 8699522094585, 8699522094592
ZA	Health Products Regulatory Authority	42/20.2.8/0941, 42/20.2.8/0942